Table 2.
Summary of data related to the laboratory findings and bladder management (n = 183).
| Laboratory findings and bladder management | |
|---|---|
| Baseline urine analyses (n = 183) | |
| White blood cell count (per mL), median (lower/upper quartiles) | 52 (11–328) |
| Increased white blood cell count (≥30/mL), n (%) | 100 (54.6) |
| Bacteria count (per mL), median (lower/upper quartiles) | 331 (16–6,709) |
| Increased bacteria count (≥6,000/mL), n (%) | 47 (25.7) |
| Days between admission and initiation of IC (n = 183), median (lower/upper quartiles) | 6.0 (0.-8.0) |
| Use of bladder irrigation (n = 183) | |
| No, n (%) | 62 (33.9) |
| Yes, n (%) | 121 (66.1) |
| Method of IC (n = 183) | |
| SIC, n (%) | 127 (69.4) |
| CIC, n (%) | 56 (30.6) |
| Cessation of IC (n = 183) | |
| No, n (%) | 114 (62.3) |
| Yes, n (%) | 69 (37.7) |
| Reasons for cessation of IC (n = 69) | |
| UTI, n (%) | 35 (50.7) |
| Recovery of voluntary voiding, n (%) | 18 (26.2) |
| Pain/bleeding/stenosis of the urethra, n (%) | 6 (8.7) |
| Failure to follow the fluid intake schedule due to comorbidities, n (%) | 5 (7.2) |
| Resistance/poor compliance to the IC intervention, n (%) | 4 (5.8) |
| Dilatation of the upper urinary tract/hydronephrosis, n (%) | 1 (1.4) |
| UTI events (n = 183) | |
| No, n (%) | 139 (76.0) |
| Yes, n (%) | 44 (24.0) |
| Days between IC initiation and UTI (n = 44), median (lower/upper quartiles) | 4.0 (1.6–8.0) |
IC, intermittent catheterization; SD, standard deviation; UTI, urinary tract infections.